Unicharm Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
As you might know, Unicharm Corporation (TSE:8113) recently reported its half-year numbers. Revenues were JP¥487b, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially better. EPS of JP¥12.35 were also better than expected, beating analyst predictions by 12%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.
Taking into account the latest results, the current consensus from Unicharm's 14 analysts is for revenues of JP¥1.00t in 2026. This would reflect an okay 3.7% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to jump 24% to JP¥46.31. Before this earnings report, the analysts had been forecasting revenues of JP¥1.00t and earnings per share (EPS) of JP¥46.29 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
View our latest analysis for Unicharm
The analysts reconfirmed their price target of JP¥1,108, showing that the business is executing well and in line with expectations. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Unicharm at JP¥1,480 per share, while the most bearish prices it at JP¥940. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.
Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Unicharm's rate of growth is expected to accelerate meaningfully, with the forecast 7.6% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 4.8% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 4.2% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Unicharm is expected to grow much faster than its industry.
The Bottom Line
The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that in mind, we wouldn't be too quick to come to a conclusion on Unicharm. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Unicharm analysts - going out to 2028, and you can see them free on our platform here.
We also provide an overview of the Unicharm Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.